Statistics found here the category is Drug-related infectious diseases (INF)

Category	Title
INF	INF-1. AIDS incidence by year of diagnosis among injecting drug users by country, cases per million, 1996 to 2006
INF	INF-2. HIV infections newly diagnosed in injecting drug users, by year of report, by country, cases per million, 1996–2006
INF	INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (i) All injecting drug users, 2005 and 2006
INF	INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (ii) Young injecting drug users (under age 25), 2005 to 2006
INF	INF-6. Estimated HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (i) Sample estimates, 2005 to 2006
INF	INF-6. Estimated HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (ii) Estimates for the sub-sample of young injecting drug users (under age 25), 2005 to 2006
INF	INF-9. Prevalence of markers of HBV infection estimated among national and subnational samples of injecting drug users 2005 to 2006, where data are available Part (i) Percentage positive for ever infected (aHBc)
INF	INF-9. Prevalence of markers of HBV infection estimated among national and subnational samples of injecting drug users 2005 to 2006, where data are available Part (ii) Percentage positive for current infection (HBsAg)
INF	INF-0. Bibliographic references
INF	INF-1. Prevalence of HIV infection among injecting drug users in the EU, 2006 or most recent year available — Summary table by country
INF	INF-2. Prevalence of HCV antibody among injecting drug users in the EU, 2006 or most recent year available — Summary table by country
INF	INF-3. Prevalence of markers for HBV infection among injecting drug users in the EU, 2006 or most recent year available — Summary table by country
INF	INF-18. Trends in HIV prevalence among injecting drug users estimated from national and sub-national samples, 2001 to 2006, samples with average prevalence above 5 %
INF	INF-19. Trends in HCV antibody prevalence in national and subnational samples of injecting drug users 2001 to 2006, countries with average prevalence above 50 %.
INF	INF-104. HIV infections newly diagnosed in injecting drug users, by year of report from 1992 to 2006, (a) cases per million population, (b) number of cases and (c) population sizes
INF	INF-105. Notified cases of hepatitis C infection among injecting drug users in the EU: number of IDU cases and percentage of IDUs amongst all cases with known risk factor
INF	INF-106. Notified cases of hepatitis B infection among injecting drug users in the EU: number of IDU cases and percentage of IDUs amongst all notified cases with known risk factor
INF	INF-107. Incidence studies of hepatitis C virus infection among injecting drug users in the EU
INF	INF-108. Prevalence of HIV infection (percentage) among injecting drug users, 1991 to 2007
INF	INF-109. Prevalence of HIV infection (percentage) among injecting drug users under age 25, 1991 to 2007
INF	INF-110. Prevalence of HIV infection (percentage) among new injecting drug users (injecting less than 2 years), 1991 to 2006
INF	INF-111. Prevalence of hepatitis C infection (percentage) among injecting drug users, 1991 to 2007
INF	INF-112. Prevalence of hepatitis C infection (percentage) among injecting drug users under age 25, 1991 to 2007
INF	INF-113. Prevalence of hepatitis C infection (percentage) among new injecting drug users (injecting less than 2 years), 1991 to 2006
INF	INF-114. Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users, 1991 to 2006
INF	INF-115. Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users, 1991 to 2006
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006 Part (i) Prevalence of HIV infection (percentage) among injecting drug users in prison
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006 Part (ii) Prevalence of hepatitis C infection (percentage) among injecting drug users in prison
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006 Part (iii) Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users in prison
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006 Part (iv) Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users in prison